AAAAAA

   
Results: 1-8 |
Results: 8
SAFETY, TOLERABILITY AND IMMUNOGENICITY OF CONCOMITANT INJECTIONS IN SEPARATE LOCATIONS OF M-M-R(R)(II), VARIVAX(R) AND TETRAMUNE(R) IN HEALTHY-CHILDREN VS. CONCOMITANT INJECTIONS OF M-M-R(R)(II) AND TETRAMUNE(R) FOLLOWED 6 WEEKS LATER BY VARIVAX(R)
Authors: SHINEFIELD HR BLACK SB STAEHLE BO ADELMAN T ENSOR K NGAI A WHITE CJ BIRD SR MATTHEWS H KUTER BJ
Citation: Hr. Shinefield et al., SAFETY, TOLERABILITY AND IMMUNOGENICITY OF CONCOMITANT INJECTIONS IN SEPARATE LOCATIONS OF M-M-R(R)(II), VARIVAX(R) AND TETRAMUNE(R) IN HEALTHY-CHILDREN VS. CONCOMITANT INJECTIONS OF M-M-R(R)(II) AND TETRAMUNE(R) FOLLOWED 6 WEEKS LATER BY VARIVAX(R), The Pediatric infectious disease journal, 17(11), 1998, pp. 980-985
SAFETY AND IMMUNOGENICITY OF CONCURRENT ADMINISTRATION OF MEASLES-MUMPS-RUBELLA-VARICELLA VACCINE AND PEDVAXHIB(R) VACCINES IN HEALTHY-CHILDREN 12 TO 18 MONTHS OLD
Authors: REUMAN PD SAWYER MH KUTER BJ MATTHEWS H CASHMORE T DUBEY L LUEVANOS L IBARRAPRATT EY NELLE CA WHITE CJ STINSON D CHO I CLEMENTS D WALTER EB KEYSERLING H PADRICK C BLATTER MM REISINGER KS LAUFER D WATSON B
Citation: Pd. Reuman et al., SAFETY AND IMMUNOGENICITY OF CONCURRENT ADMINISTRATION OF MEASLES-MUMPS-RUBELLA-VARICELLA VACCINE AND PEDVAXHIB(R) VACCINES IN HEALTHY-CHILDREN 12 TO 18 MONTHS OLD, The Pediatric infectious disease journal, 16(7), 1997, pp. 662-667
SAFETY AND IMMUNOGENICITY OF ONE VS 2 INJECTIONS OF OKA MERCK VARICELLA VACCINE IN HEALTHY-CHILDREN/
Authors: NGAI AL STAEHLE BO KUTER BJ CYANOVICH NM CHO I MATTHEWS H KELLER P ARVIN AM WATSON B WHITE CJ ANDERSON R ARBETER A ARVIN AM BLACK S BLOCK SL BLUMBERG D BRUNELL PA CHARTRAND SA CLEMENTS DA DENNEHY P KEYSERLING H NAUERT B REISINGER KS RENNELS MB REUMAN PD SHEHAB ZM STARR SE TUCKER R
Citation: Al. Ngai et al., SAFETY AND IMMUNOGENICITY OF ONE VS 2 INJECTIONS OF OKA MERCK VARICELLA VACCINE IN HEALTHY-CHILDREN/, The Pediatric infectious disease journal, 15(1), 1996, pp. 49-54
DURATION OF PROTECTION FROM CLINICAL HEPATITIS-A DISEASE AFTER VACCINATION WITH VAQTA(R)
Authors: WIENS BL BOHIDAR NR PIGEON JG EGAN J HURNI W BROWN L KUTER BJ NALIN DR
Citation: Bl. Wiens et al., DURATION OF PROTECTION FROM CLINICAL HEPATITIS-A DISEASE AFTER VACCINATION WITH VAQTA(R), Journal of medical virology, 49(3), 1996, pp. 235-241
SAFETY AND IMMUNOGENICITY OF A COMBINED LIVE ATTENUATED MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE (MMR(II)V) IN HEALTHY-CHILDREN (VOL 173, PG 731, 1996)
Authors: WATSON BM LAUFER DS KUTER BJ STAEHLE B WHITE CJ STARR SE
Citation: Bm. Watson et al., SAFETY AND IMMUNOGENICITY OF A COMBINED LIVE ATTENUATED MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE (MMR(II)V) IN HEALTHY-CHILDREN (VOL 173, PG 731, 1996), The Journal of infectious diseases, 173(6), 1996, pp. 1529-1529
SAFETY AND IMMUNOGENICITY OF A COMBINED LIVE ATTENUATED MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE (MMT(II)V) IN HEALTHY-CHILDREN
Authors: WATSON BM LAUFER DS KUTER BJ STAEHLE B WHITE CJ
Citation: Bm. Watson et al., SAFETY AND IMMUNOGENICITY OF A COMBINED LIVE ATTENUATED MEASLES, MUMPS, RUBELLA, AND VARICELLA VACCINE (MMT(II)V) IN HEALTHY-CHILDREN, The Journal of infectious diseases, 173(3), 1996, pp. 731-734
SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 2 REGIMENS OF OKA MERCK VARICELLA VACCINE (VARIVAX(R)) IN HEALTHY ADOLESCENTS AND ADULTS/
Authors: KUTER BJ NGAI A PATTERSON CM STAEHLE BO CHO IS MATTHEWS H PROVOST PJ WHITE CJ ARVIN A ARBETER A BALFOUR H BLUMBERG D BRUNELL P CHARTRAND S CHERRY J CLEMENTS D DAVIDSON M DEMMLER G DENNEHY P GERSHON A HARRIS A HAYDEN F JACOBSON J KESSLER H KUMAR M LAW B LEVIN M MAURER H OXMAN M REISINGER K SNYDMAN D SAVOIA M STARR S WHITLEY R WONG V YOGEV R
Citation: Bj. Kuter et al., SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF 2 REGIMENS OF OKA MERCK VARICELLA VACCINE (VARIVAX(R)) IN HEALTHY ADOLESCENTS AND ADULTS/, Vaccine, 13(11), 1995, pp. 967-972
WORLDWIDE EXPERIENCE WITH THE CR326F-DERIVED INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PEDIATRIC AND ADULT-POPULATIONS - AN OVERVIEW
Authors: NALIN DR KUTER BJ BROWN L PATTERSON C CALANDRA GB WERZBERGER A SHOUVAL D ELLERBECK E BLOCK SL BISHOP R WIENS B SCHWARTZ SW LEWIS JA SITRIN RD PROVOST PJ MILLER WJ RYAN JL
Citation: Dr. Nalin et al., WORLDWIDE EXPERIENCE WITH THE CR326F-DERIVED INACTIVATED HEPATITIS-A VIRUS-VACCINE IN PEDIATRIC AND ADULT-POPULATIONS - AN OVERVIEW, Journal of hepatology, 18, 1993, pp. 190000051-190000055
Risultati: 1-8 |